Nbome

25I-NBOMe (2C-I-NBOMe, Cimbi-5, also shortened to “25I “). Firstly, A derivative of the substituted phenethylamine 2C-I family, it is the most well-known member of the 25-NB family dissertation. The compound was subsequently investigated by a team at Purdue University led by David Nichols.

Therefore, The carbon-11 labelled version of 25I-NBOMe, ^[11C]Cimbi-5, was synthesized and validated as a radiotracer for positron emission tomography (PET) in Copenhagen. Being the first 5-HT_2A receptor full agonist PET radioligand, ^[11C]-CIMBI-5 shows promise as a more functional marker of these receptors, particularly in their high affinity states.

Street and media nicknames for this drug are: “N-Bomb”, “Solaris”, “Smiles” or “Wizard Medication”.

25I-NBOMe powder Recreational use

Secondly, By 2013, case reports of 25I-NBOMe intoxication, with and without analytic confirmation of the drug in the body, were becoming increasingly common in the medical literature.

However, apparent overdoses have occurred via oral administration. Common routes of administration include sublingual, buccal, and intranasal. For sublingual and buccal administration, 25I-NBOMe is often applied to sheets of blotter paper of which small portions (tabs) are held in the mouth to allow absorption through the oral mucosa. There are reports of intravenous injection of 25I-NBOMe solution and smoking the drug in powdered form.

Due to its potency and much lower cost than so-called classical or traditional psychedelics. Even small quantities of 25I-NBOMe can produce a large number of blotters. Vendors would import 25I-NBOMe in bulk (E.G 1 kilogram containers) and resell individual doses for a considerable profit.

25I-NBOMe powder Dosage

25I-NBOMe is potent, being active in sub-milligram doses. A common dose of the hydrochloride salt is 600–1,200 µg. The UK Advisory Council on the Misuse of Drugs states that a common dose is between 50 and 100 µg, although other sources indicate that these figures are incorrect; Erowid tentatively suggests that the threshold dosage for humans is 50–250 µg. With a light dose between 200–600 µg, a common dose at 500–800 µg, and a strong dose at 700–1500 µg. At this level of potency, it is not possible to accurately measure a single dose of 25I-NBOMe powder without an analytical balance, and attempting to do so may put the user at significant risk of overdose.

RECREATION

It is unclear what other drugs he may have consumed. As autopsies generally do not test for the presence of research chemicals. In January 2013, an 18-year-old in Scottsdale, Arizona, died after consuming 25I-NBOMe sold as LSD; a toxicology screening found no other drugs in the person’s system. The drug is the suspected cause of death in another Scottsdale, Arizona, incident in April 2013. It is also cited in the death of a 21-year-old woman in August 2013 and the death of a 17-year-old in Minnesota in January 2014, as well as the death of a 15-year old in Washington in September 2014.

nbome login

A Sydney teenager jumped to his death on June 5, 2013. He reportedly jumped off a balcony thinking he could fly.

Which left six teenagers hospitalized, one of whom later died. At least one of the teenagers suffered a cardiac arrest, according to reports, along with extreme internal bleeding.

25I-NBOMe presumably exhibits functional selectivity at the 5HT_2A receptor similar to other phenethylamine hallucinogens, activating the Phospholipase A2 signal cascade, which is responsible for the release of Thromboxane A2, triggering blood platelet aggregation